2024년에 73억 달러로 추정되는 미세유체 디바이스 시스템 세계 시장은 2024년부터 2030년까지 CAGR 19.3%로 성장하여 2030년에는 210억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 체외진단은 CAGR 19.3%를 기록하며 분석 기간 종료시에는 133억 달러에 달할 것으로 예측됩니다. 의약품 부문의 성장률은 분석 기간 동안 CAGR 16.7%로 추정됩니다.
미국 시장은 21억 달러로 추정, 중국은 CAGR 18.8%로 성장 예측
미국의 미세유체 디바이스 시스템 시장은 2024년에 21억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 33억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 18.8%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 16.9%와 16.1%로 예측됩니다. 유럽에서는 독일이 CAGR 약 13.2%로 성장할 것으로 예측됩니다.
세계 미세유체 디바이스 시스템 시장 - 주요 동향 및 촉진요인 정리
미세유체 디바이스 시스템이란 무엇이며, 왜 현대 바이오 의료 및 산업 응용 분야에서 중요한가?
미세유체 디바이스 시스템은 칩에 에칭된 유로를 통해 소량의 유체(일반적으로 마이크로 리터 또는 나노 리터 범위)를 조작하여 화학적, 생물학적, 물리적 공정을 정밀하게 제어할 수 있는 소형화된 플랫폼입니다. 이러한 장치는 펌프, 밸브, 센서, 믹서 등의 구성 요소를 통합하여 진단, 약물 전달, 화학 분석, 환경 모니터링 등 다양한 응용 분야를 가능하게 합니다. 마이크로유체공학은 빠른 처리 속도, 시약 소비 감소, 저비용, 민감도 향상 등의 이점을 제공하여 의료, 제약, 식품 안전, 연구 등의 분야에서 중요한 기술이 되고 있습니다.
미세유체 디바이스 시스템의 중요성은 신속하고 정확하며 비용 효율적인 유체 분석 및 합성을 제공하는 능력에 있으며, 이를 통해 포인트 오브 케어 진단, 랩온칩 기술 및 하이스루풋 스크리닝의 발전을 가능하게 합니다. 마이크로유체공학은 실험실 공정의 소형화를 통해 개인화된 의료, 효율적인 신약 개발, 실시간 환경 모니터링을 지원합니다. 산업계가 더 높은 정확도, 더 나은 자동화, 더 지속가능한 공정을 추구함에 따라 미세유체 시스템은 현대 생물 의학 연구, 임상 진단 및 산업 응용 분야에서 필수적인 도구가 되고 있습니다.
기술 발전은 미세유체 디바이스 시스템 시장을 어떻게 형성하고 있는가?
기술의 발전은 미세유체 디바이스 시스템의 정확성, 다양성 및 통합 능력을 크게 향상시켜 다양한 응용 분야에서 혁신을 촉진하고 있습니다. PDMS(폴리디메틸실록산(PDMS), 유리, 고리형 올레핀 공중합체(COC) 등 생체 적합성, 내화학성, 광학 투명성을 향상시키는 첨단 소재의 사용이 그 중 하나입니다. 이러한 재료는 마이크로 유체 장치의 성능과 신뢰성을 향상시켜 복잡한 분석, 약물 전달 시스템, 실시간 진단에 적합합니다.
자동 제어 시스템의 통합은 마이크로 유체 장치의 기능을 더욱 향상시켰습니다. 자동화된 플랫폼에는 센서, 액추에이터 및 소프트웨어가 내장되어 있어 유체 흐름, 온도 및 압력을 실시간으로 모니터링하고 조작할 수 있습니다. 이 기능은 전기 신호를 사용하여 칩의 미세한 물방울을 조작하여 신속하고 정밀한 생화학 분석을 가능하게 하는 디지털 미세유체 공학 같은 응용 분야에서 매우 중요합니다. 자동화는 처리량과 정확도를 향상시킬 뿐만 아니라 인간의 개입을 줄이고 마이크로 유체 시스템을 보다 확장 가능하며 산업계의 요구에 맞게 조정할 수 있습니다.
3D 프린팅과 미세 가공 기술의 발전은 미세유체 장치 설계의 가능성을 넓혔으며, 3D 프린팅은 복잡한 미세유체 구조의 신속한 프로토타이핑을 가능하게 하여 진단, 의약품 개발, 환경 테스트와 같은 특정 용도에 맞는 맞춤형 장치 설계를 지원합니다. 지원합니다. 소프트 리소그래피 및 포토리소그래피와 같은 미세 가공의 혁신은 미세유체 칩 내 부품의 소형화 및 통합을 개선하고 여러 분석 기능을 하나의 장치에 통합한 랩온칩(lab-on-a-chip) 장치를 개발할 수 있게 해줍니다. 이러한 기술 혁신은 마이크로 유체 시스템의 용량을 확장할 뿐만 아니라, 바이오메디컬 및 산업 공정의 소형화, 자동화, 고정밀화라는 광범위한 트렌드와도 일치합니다.
다양한 분야에서 미세유체 디바이스 시스템의 새로운 응용 사례는 무엇인가?
미세유체 디바이스 시스템은 높은 정확도, 비용 효율적이고 신속한 분석 도구에 대한 요구에 힘입어 다양한 분야에서 응용이 확대되고 있습니다. 헬스케어 분야에서는 마이크로유체공학은 현장 진단에 널리 사용되고 있으며, 감염, 암, 심혈관질환 등의 질병을 신속하게 검사할 수 있게 해줍니다. 샘플 조제, 반응 및 검출을 하나의 칩에 통합한 랩온칩 장치는 혈액 검사, 포도당 모니터링, 유전자 분석에 사용되어 맞춤형 의료 및 질병 조기 발견을 지원합니다. 마이크로 유체 장치는 또한 약물 효과와 질병 진행을 테스트하기 위해 인간의 장기 기능을 시뮬레이션하는 장기 온 어 칩 모델에도 사용되어 동물 모델에 대한 의존도를 줄이고 의약품 개발을 가속화하고 있습니다.
제약 업계에서는 미세유체공학은 신약개발 및 개발에 있어 중요한 역할을 하고 있습니다. 미세유체는 약물 후보물질의 고처리량 스크리닝, 나노 의약품의 효율적인 합성, 약물전달 시스템의 제어를 가능하게 합니다. 마이크로유체 플랫폼을 통해 연구자들은 신속한 분석, 세포 수준에서의 약물 상호작용 연구, 크기와 조성을 정밀하게 제어할 수 있는 리포솜 및 나노입자와 같은 복잡한 제제를 만들 수 있습니다. 이러한 기능은 약효를 향상시키고, 부작용을 줄이며, 개발 기간을 단축할 수 있기 때문에 미세유체 공학은 현대 의약품 연구에 필수적인 요소로 자리 잡고 있습니다.
환경 분야에서는 수질, 토양 분석, 오염물질 검출의 실시간 모니터링에 미세유체 장치가 사용되고 있습니다. 중금속, 병원균, 농약 등 오염물질에 대한 신속한 현장 검사가 가능해져 환경 보호 및 지속가능한 관리 노력을 지원하고 있습니다. 식음료 업계에서는 미세유체 시스템은 품질 관리를 위해 식품의 병원균, 알레르겐, 화학 오염물질을 검출하기 위해 채택되었습니다. 신속하고 정확한 결과를 제공하는 미세유체 시스템은 식품 안전을 보장하고 규제 기준을 준수하기 위한 귀중한 도구입니다. 이러한 분야에서 미세유체 디바이스 시스템의 적용이 확대되고 있는 것은 미세유체 디바이스 시스템이 소비자 및 산업 분야 모두에서 정확하고 효율적이며 확장 가능한 분석 솔루션을 구현하는 데 중요한 역할을 하고 있다는 것을 보여줍니다.
미세유체 디바이스 시스템 시장의 성장 원동력은?
미세유체 디바이스 시스템 시장의 성장은 신속한 진단에 대한 수요 증가, 정밀 의료의 발전, 신약 개발 및 환경 모니터링 분야에서의 채택 증가 등 여러 가지 요인에 의해 이루어지고 있습니다. 주요 성장 요인 중 하나는 POC(Point-of-Care) 진단과 분산형 헬스케어 솔루션이 세계를 주도하고 있습니다. 의료 서비스 제공자가 접근성 향상, 비용 절감, 신속한 결과 제공을 목표로 하는 가운데, 미세유체 시스템은 병상, 진료소, 원격지에서 검사를 수행할 수 있는 확장 가능한 솔루션을 제공합니다. 작은 크기, 빠른 처리 시간, 최소한의 샘플 요구 사항으로 신속한 질병 검사 및 모니터링에 이상적입니다.
개인화 의료가 중시되면서 미세유체 디바이스 시스템에 대한 수요는 더욱 증가하고 있습니다. 정밀의료에서는 개인의 유전적, 환경적, 생활습관적 요인에 기반한 맞춤형 치료 계획이 필요하기 때문에 마이크로유체 디바이스는 유전자 분석 및 바이오마커 분석의 효율적인 처리를 가능하게 하여 맞춤형 치료의 선택과 모니터링을 지원합니다. 이러한 수요는 맞춤형 치료 접근법이 환자 예후에 필수적인 종양학, 감염성 질환, 대사성 질환 등의 분야에서 특히 강세를 보이고 있습니다.
신약개발 및 의약품 개발의 발전은 미세유체 장치의 채택에도 기여하고 있습니다. 제약사들은 마이크로유체 플랫폼을 사용하여 약물 후보물질의 고처리량 스크리닝, 신속한 제형화 및 시험에 사용함으로써 개발 시간과 비용을 절감하고 있습니다. 혼합, 반응, 검출 등 여러 기능을 하나의 장치에 통합할 수 있어 보다 효율적인 워크플로우가 가능하기 때문에 제약 연구 및 바이오 제조 분야에서 미세유체의 매력이 더욱 커지고 있습니다.
환경 모니터링에 대한 요구가 증가하고 물, 토양, 식품 안전에 대한 규제가 강화됨에 따라 오염물질과 병원균을 신속하게 검출하기 위한 마이크로 유체 장치의 활용이 증가하고 있습니다. 휴대성, 정확성, 적은 시약 소비량으로 인해 선진국과 신흥 시장에서 실시간 모니터링에 효과적인 도구가 되어 지속가능한 관리와 규제 준수를 지원하고 있습니다.
재료, 소형화 및 통합 기술의 혁신이 진행됨에 따라 미세유체 디바이스 시스템 시장은 강력한 성장세를 보이고 있습니다. 이러한 추세는 빠르고 정확하며 비용 효율적인 분석 솔루션에 대한 수요 증가와 함께 미세유체 공학을 의료 개선, 의약품 개발 가속화, 다양한 분야의 지속가능한 관행 지원에 초점을 맞춘 현대적 전략의 핵심 요소로 만들고 있습니다.
Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.
Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범에 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global Microfluidic Device Systems Market to Reach US$21.0 Billion by 2030
The global market for Microfluidic Device Systems estimated at US$7.3 Billion in the year 2024, is expected to reach US$21.0 Billion by 2030, growing at a CAGR of 19.3% over the analysis period 2024-2030. In-vitro diagnostics, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$13.3 Billion by the end of the analysis period. Growth in the Pharmaceuticals segment is estimated at 16.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 18.8% CAGR
The Microfluidic Device Systems market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 18.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.9% and 16.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.
Global Microfluidic Device Systems Market - Key Trends & Drivers Summarized
What Are Microfluidic Device Systems, and Why Are They So Crucial in Modern Biomedical and Industrial Applications?
Microfluidic Device Systems are miniaturized platforms that manipulate small volumes of fluids (typically in the microliter or nanoliter range) through channels etched on a chip, enabling precise control of chemical, biological, and physical processes. These devices integrate components like pumps, valves, sensors, and mixers, allowing for various applications such as diagnostics, drug delivery, chemical analysis, and environmental monitoring. Microfluidics offers advantages like faster processing, reduced reagent consumption, lower costs, and improved sensitivity, making it a key technology in sectors like healthcare, pharmaceuticals, food safety, and research.
The importance of microfluidic device systems lies in their ability to provide rapid, accurate, and cost-effective analysis and synthesis of fluids, enabling advancements in point-of-care diagnostics, lab-on-a-chip technologies, and high-throughput screening. By miniaturizing laboratory processes, microfluidics supports personalized medicine, efficient drug discovery, and real-time environmental monitoring. As industries aim for higher precision, better automation, and more sustainable processes, microfluidic systems have become essential tools in modern biomedical research, clinical diagnostics, and industrial applications.
How Are Technological Advancements Shaping the Microfluidic Device Systems Market?
Technological advancements have significantly enhanced the precision, versatility, and integration capabilities of Microfluidic Device Systems, driving innovation across diverse applications. One of the major developments is the use of advanced materials, such as PDMS (polydimethylsiloxane), glass, and cyclic olefin copolymers (COCs), which offer improved biocompatibility, chemical resistance, and optical transparency. These materials enhance the performance and reliability of microfluidic devices, making them suitable for complex assays, drug delivery systems, and real-time diagnostics.
The integration of automated control systems has further improved the functionality of microfluidic devices. Automated platforms incorporate sensors, actuators, and software that enable real-time monitoring and manipulation of fluid flow, temperature, and pressure. This capability is crucial in applications like digital microfluidics, where electrical signals are used to manipulate tiny droplets on a chip, enabling rapid and precise biochemical assays. Automation not only increases throughput and accuracy but also reduces human intervention, making microfluidic systems more scalable and adaptable to industrial needs.
Advancements in 3D printing and microfabrication techniques have expanded the design possibilities of microfluidic devices. 3D printing allows for rapid prototyping of complex microfluidic structures, supporting customized device designs for specific applications in diagnostics, drug development, and environmental testing. Innovations in microfabrication, such as soft lithography and photolithography, have improved the miniaturization and integration of components within microfluidic chips, enabling the development of lab-on-a-chip devices that combine multiple analytical functions in a single device. These technological innovations not only expand the capabilities of microfluidic systems but also align with broader trends toward miniaturization, automation, and precision in biomedical and industrial processes.
What Are the Emerging Applications of Microfluidic Device Systems Across Different Sectors?
Microfluidic Device Systems are finding expanding applications across various sectors, driven by the need for high-precision, cost-effective, and rapid analytical tools. In the healthcare sector, microfluidics is widely used in point-of-care diagnostics, enabling rapid tests for conditions like infectious diseases, cancer, and cardiovascular disorders. Lab-on-a-chip devices, which integrate sample preparation, reaction, and detection on a single chip, are used for blood testing, glucose monitoring, and genetic analysis, supporting personalized medicine and early disease detection. Microfluidic devices are also used in organ-on-a-chip models, which simulate human organ functions to test drug effects and disease progression, reducing the reliance on animal models and accelerating drug development.
In the pharmaceutical industry, microfluidics plays a critical role in drug discovery and development. It enables high-throughput screening of drug candidates, efficient synthesis of nanomedicines, and controlled drug delivery systems. Microfluidic platforms allow researchers to perform rapid assays, study drug interactions at the cellular level, and create complex formulations like liposomes and nanoparticles with precise control over size and composition. These capabilities enhance drug efficacy, reduce side effects, and shorten development timelines, making microfluidics indispensable in modern drug research.
In the environmental sector, microfluidic devices are used for real-time monitoring of water quality, soil analysis, and detection of pollutants. They enable rapid, on-site testing for contaminants like heavy metals, pathogens, and pesticides, supporting efforts in environmental protection and sustainable management. In the food and beverage industry, microfluidic systems are employed for quality control, detecting pathogens, allergens, and chemical contaminants in food products. Their ability to provide quick and accurate results makes them valuable tools for ensuring food safety and compliance with regulatory standards. The expanding applications of microfluidic device systems across these sectors highlight their critical role in enabling precise, efficient, and scalable analytical solutions in both consumer and industrial settings.
What Drives Growth in the Microfluidic Device Systems Market?
The growth in the Microfluidic Device Systems market is driven by several factors, including increasing demand for rapid diagnostics, advancements in precision medicine, and rising adoption in drug discovery and environmental monitoring. One of the primary growth drivers is the global push for point-of-care diagnostics and decentralized healthcare solutions. As healthcare providers aim to improve access, reduce costs, and deliver faster results, microfluidic systems offer a scalable solution for performing tests at the bedside, in clinics, or in remote locations. Their small size, rapid turnaround, and minimal sample requirements make them ideal for quick disease screening and monitoring.
The growing emphasis on personalized medicine has further fueled demand for microfluidic device systems. As precision medicine requires tailored treatment plans based on individual genetic, environmental, and lifestyle factors, microfluidic devices enable efficient processing of genetic and biomarker analyses, supporting personalized therapy selection and monitoring. This demand is particularly strong in fields like oncology, infectious diseases, and metabolic disorders, where individualized treatment approaches are critical for patient outcomes.
Advancements in drug discovery and development have also contributed to the adoption of microfluidic devices. Pharmaceutical companies use microfluidic platforms for high-throughput screening, rapid formulation, and testing of drug candidates, reducing development time and costs. The ability to integrate multiple functions, such as mixing, reaction, and detection, in a single device supports more efficient workflows, increasing the appeal of microfluidics in drug research and biomanufacturing.
Rising environmental monitoring needs and stricter regulations for water, soil, and food safety have driven the use of microfluidic devices for rapid detection of contaminants and pathogens. Their portability, accuracy, and low reagent consumption make them effective tools for real-time monitoring in both developed and emerging markets, supporting sustainable management and regulatory compliance.
With ongoing innovations in materials, miniaturization, and integration technologies, the microfluidic device systems market is poised for robust growth. These trends, combined with increasing demand for rapid, accurate, and cost-effective analytical solutions, make microfluidics a vital component of modern strategies focused on improving healthcare, accelerating drug development, and supporting sustainable practices across various sectors.
SCOPE OF STUDY:
The report analyzes the Microfluidic Device Systems market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Application (Point of Care Testing, Pharmaceutical and Life Science Research, Drug Delivery, Analytical Devices, Clinical and Veterinary Diagnostics, Environment and Industrial); Industry (In-vitro Diagnostics, Pharmaceuticals, Medical Devices)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 23 Featured) -
Abbott Laboratories
Agilent Technologies, Inc.
Becton, Dickinson & Company
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
Dolomite Microfluidics
Fluidigm Corporation
Johnson & Johnson
Micronit Microtechnologies B.V.
RainDance Technologies, Inc.
Roche Diagnostics (Schweiz) AG
Siemens Healthineers
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Microfluidic Device Systems - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Demand for Point-of-Care Diagnostics Drives Microfluidic Device Adoption
Advancements in Lab-on-a-Chip Technology Propel Market Growth
Increasing Use in Drug Discovery Expands Microfluidics Market Opportunities
Miniaturization of Medical Devices Strengthens Business Case for Microfluidics
Expanding Use in Genomics and Proteomics Sets the Stage for Growth
Strong Demand for Rapid Testing During Disease Outbreaks Generates Demand
Use in Cell Analysis and Manipulation Expands Addressable Market
Growing Focus on Organ-on-Chip Technology Drives Microfluidics Adoption
Expanding Applications in Food Safety Testing Spur Microfluidic Adoption
Growing Use in Environmental Monitoring Generates Demand for Devices
Rising Focus on Microfluidics in Biopharmaceutical Production Sustains Growth
Increasing Demand for Home Healthcare Devices Sets the Stage for Microfluidics Expansion
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Microfluidic Device Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for In-vitro diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Point of care testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Pharmaceutical and life science research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Drug delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Analytical devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Clinical and veterinary diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Environment and Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 32: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: USA Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: USA 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: USA Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: USA 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: Canada 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: Canada 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
JAPAN
Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 44: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: Japan 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 47: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: Japan 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
CHINA
Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 50: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: China Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: China 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 53: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: China Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: China 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
EUROPE
Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 56: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Europe 15-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Europe 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Europe 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
FRANCE
Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 65: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: France Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: France 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 68: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: France Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: France 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
GERMANY
Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 71: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: Germany 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 74: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Germany Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: Germany 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
ITALY
TABLE 77: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: Italy 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 80: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Italy Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Italy 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
UNITED KINGDOM
Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 83: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: UK Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: UK 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 86: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: UK Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: UK 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Rest of Europe 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Rest of Europe 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Asia-Pacific 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Asia-Pacific 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
REST OF WORLD
TABLE 101: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Rest of World Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Rest of World 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
TABLE 104: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Rest of World Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Rest of World 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
